DYS-HAC-iPS cells: The combination of gene and cell therapy to treat duchenne muscular dystrophy

Molecular Therapy

Volumn 18, Issue 2, 2010, Pages 238-240

  Park, In Hyun ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD146 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; DYSTROPHIN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSCRIPTION FACTOR SOX2;

ALLOTRANSPLANTATION; ARTIFICIAL CHROMOSOME; CARCINOGENICITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CELL THERAPY; CYTOSKELETON; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION; GENE LOCUS; GENE THERAPY; GENE TRANSFER; HUMAN; NONHUMAN; NOTE; PLURIPOTENT STEM CELL; POINT MUTATION; SATELLITE CELL;

IPS;

EID: 76249099025     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.303     Document Type: Note

References (25)

1. Wallace, GQ and McNally, EM (2009). Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu Rev Physiol 71: 37-57.
2. Kazuki, Y, Hiratsuka, M, Takiguchi, M, Osaki, M, Kaji-tani, N, Hoshiya, H, et al. (2010). Complete genetic correction of iPS cells from Duchenne muscular dystrophy. Mol Ther. 18: 386-393.
3. Odom, GL, Gregorevic, P and Chamberlain, JS (2007). Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances. Biochim Biophys Acta 1772: 243-262.
4. Hoshiya, H, Kazuki, Y, Abe, S, Takiguchi, M, Kajitani, N, Watanabe, Y, et al. (2009). A highly stable and noninte-grated human artifcial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene. Mol Ther. 17: 309-317.
5. Park, IH, Zhao, R, West, JA, Yabuuchi, A, Huo, H, Ince, TA, et al. (2008). Reprogramming of human somatic cells to pluripotency with defned factors. Nature 451: 141-146.
6. Takahashi, K, Tanabe, K, Ohnuki, M, Narita, M, Ichisaka, T, Tomoda, K, et al. (2007). Induction of pluripotent stem cells from adult human fbroblasts by defned factors. Cell 131: 861-872.
7. Nishikawa, S, Goldstein, RA and Nierras, CR (2008). The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 9: 725-729.
8. Okita, K, Ichisaka, T and Yamanaka, S (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
9. Yu, J, Hu, K, Smuga-Otto, K, Tian, S, Stewart, R, Slukvin, II, et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.
10. Okita, K, Nakagawa, M, Hyenjong, H, Ichisaka, T and Yamanaka, S (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322: 949-953.
11. Kim, D, Kim, CH, Moon, JI, Chung, YG, Chang, MY, Han, BS, et al. (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogram-ming proteins. Cell Stem Cell 4: 472-476.
12. Stadtfeld, M, Nagaya, M, Utikal, J, Weir, G, and Hochedlinger, K (2008). Induced pluripotent stem cells generated without viral integration. Science 322: 945-949.
13. Peault, B, Rudnicki, M, Torrente, Y, Cossu, G, Tremblay, J P, Partridge, T, et al. (2007). Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 15, 867-877. (Pubitemid 46621645)
14. Kuang, S and Rudnicki, MA (2008). The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med 14, 82-91.
15. Alessandri, G, Pagano, S, Bez, A, Benetti, A, Pozzi, S, Iannolo, G, et al. (2004). Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364: 1872-1883.
16. Asakura, A, Seale, P, Girgis-Gabardo, A and Rudnicki, MA (2002). Myogenic specifcation of side population cells in skeletal muscle. J Cell Biol 159: 123-134.
17. Dezawa, M, Ishikawa, H, Itokazu, Y, Yoshihara, T, Hoshino, M, Takeda, S, et al. (2005). Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309: 314-317.
18. Sampaolesi, M, Blot, S, D'Antona, G, Granger, N, Ton-lorenzi, R, Innocenzi, A, et al. (2006). Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444: 574-579.
19. Dellavalle, A, Sampaolesi, M, Tonlorenzi, R, Tagliafco, E, Sacchetti, B, Perani, L, et al. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9: 255-267.
20. Benchaouir, R, Meregalli, M, Farini, A, D'Antona, G, Belicchi, M, Goyenvalle, A, et al. (2007). Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 1, 646-657.
21. Barberi, T, Bradbury, M, Dincer, Z, Panagiotakos, G, Socci, ND and Studer, L (2007). Derivation of engraft-able skeletal myoblasts from human embryonic stem cells. Nat Med 13: 642-648.
22. Darabi, R, Gehlbach, K, Bachoo, RM, Kamath, S, Osawa, M, Kamm, KE, et al. (2008). Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med 14: 134-143.
23. Skuk, D and Tremblay, JP (2000). Progress in myoblast transplantation: a potential treatment of dystrophies. Microsc Res Tech 48: 213-222.
24. Skuk, D and Tremblay, JP (2003). Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J Muscle Res Cell Motil 24: 285-300.
25. Sakurai, H, Okawa, Y, Inami, Y, Nishio, N and Isobe, K (2008). Paraxial mesodermal progenitors derived from mouse embryonic stem cells contribute to muscle regeneration via differentiation into muscle satellite cells. Stem Cells 26: 1865-1873.